Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 04, 2026 09:00 ET | Source: Stipple Bio, Inc.

Stipple Bio Enters Multi-Target License Agreement with Lonza to Advance Precision Oncology ADC Therapies

– Multi-target agreement positions Stipple Bio to advance next-generation ADC therapies using Lonza’s clinically validated ADC platform — — Stipple Bio’s Pointillist Platform identifies...